AORT
Artivion Inc
NYSE · Health Care
$39.59
+0.13 (+0.33%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 441.67M | 404.68M | 573.88M | 567.61M | 632.56M |
| Net Income | -15,183,666 | -12,520,890 | 68.43M | 80.88M | 71.76M |
| EPS | — | — | — | — | — |
| Profit Margin | -3.4% | -3.3% | 11.9% | 14.3% | 11.3% |
| Rev Growth | +9.1% | +9.1% | +10.2% | +0.5% | +23.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 501.71M | 501.71M | 484.78M | 574.09M | 622.05M |
| Total Equity | 436.08M | 436.08M | 755.53M | 723.37M | 855.76M |
| D/E Ratio | 1.15 | 1.15 | 0.64 | 0.79 | 0.73 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 41.35M | 36.00M | 109.42M | 104.46M | 115.56M |
| Free Cash Flow | — | — | 36.37M | 35.10M | 56.92M |